| 标题 |
Efficacy and safety of intravenous induction and subcutaneous maintenance therapy with guselkumab for patients with Crohn's disease (GALAXI-2 and GALAXI-3): 48-week results from two phase 3, randomised, placebo and active comparator-controlled, double-blind, triple-dummy trials guselkumab静脉诱导和皮下维持治疗克罗恩病患者(GALAXI-2和GALAXI-3)的有效性和安全性:两项3期、随机、安慰剂和活性对照药物对照、双盲、三模拟试验的48周结果
|
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Remo Panaccione; Brian G Feagan; Anita Afzali; David T Rubin; Walter Reinisch; et al 出版日期:2025 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |